Showing results (1661-1670 of 2,139) with videos related to
Sort By:
Pageof 214
Transfusion|August 21, 2004
Hypotensive transfusion reactions can occur with blood products that are leukoreduced before storageDonald M Arnold, Giuseppe Molinaro, Theodore E Warkentin, et al.Biorxiv : the Preprint Server for Biology|October 7, 2024
Cryo-electron tomography pipeline for plasma membranesWilly W Sun, Dennis J Michalak, Kem A Sochacki, et al.Seminars in Arthritis and Rheumatism|December 31, 2020
The Prevalence of Psychiatric and Chronic Pain Comorbidities in Fibromyalgia: an ACTTION systematic reviewBethea A Kleykamp, McKenzie C Ferguson, Ewan McNicol, et al.BMC Anesthesiology|November 27, 2013
Adjunctive aerosolized colistin for multi-drug resistant gram-negative pneumonia in the critically ill: a retrospective studyNeha M Doshi, Charles H Cook, Kari L Mount, et al.AJOB Empirical Bioethics|August 11, 2020
Prioritizing Initiatives for Institutional Review Board (IRB) Quality ImprovementDaniel E Hall, Ulrike Feske, Barbara H Hanusa, et al.Journal of Critical Care|November 29, 2005
Thrombocytopenia in medical-surgical critically ill patients: prevalence, incidence, and risk factorsMark A Crowther, Deborah J Cook, Maureen O Meade, et al.Transfusion Medicine Reviews|September 19, 2025
Artificial Intelligence and Machine Learning in Transfusion Practice: An Analytical AssessmentNa Li, Ruchika Goel, Sheharyar Raza, et al.Psycho-Oncology|March 6, 2024
"Pathways": A hope-enhancing intervention for patients undergoing treatment for advanced lung cancerLaurie E McLouth, Brent J Shelton, Vilma Bursac, et al.Oncotarget|September 18, 2015
Differential regulation of metabolic pathways by androgen receptor (AR) and its constitutively active splice variant, AR-V7, in prostate cancer cellsAyesha A Shafi, Vasanta Putluri, James M Arnold, et al.Pain|April 9, 2008
Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trialJon I Russell, Philip J Mease, Timothy R Smith, et al.Pageof 214